Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
NCT02281136
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Keratosis, Actinic
Interventions
DRUG:
Aminolevulinic Acid (ALA)
DEVICE:
BLU-U
Sponsor
DUSA Pharmaceuticals, Inc.